MolNFT v1 · #166140 · protein
Crystal structure of the Fc fragment of anti-tnfa antibody infliximab (remicade) in a primative orthorhombic crystal form, lot C
6UGY: “Crystal structure of the Fc fragment of anti-tnfa antibody infliximab (remicade) in a primative orthorhombic…”. X-ray diffraction, 6 ligands (NAG, MAN, BMA). MolNFT v1 #166140 on GenesisL1: 3D structure, binding sites and pockets in…
- PDB
- 6UGY
- Type
- protein
- Length
- 206 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P0DOX5
- Ligands
- NAG, MAN, BMA, GAL, FUC, ZN
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 206 | — | P0DOX5 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A
- MAN · alpha-D-mannopyranose · sugar · 2 copies · chains A
- BMA · beta-D-mannopyranose · sugar · chains A
- GAL · beta-D-galactopyranose · sugar · chains A
- FUC · alpha-L-fucopyranose · sugar · chains A
- ZN · Zinc ion · metal · 3 copies · chains A
- ACT · Acetate ion · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 6UGY · Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0DOX5
- Elsewhere: RCSB PDB 6UGY · PDBe 6UGY · UniProt P0DOX5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.